Innovative submucosal injection solution for endoscopic resection with phosphorylated pullulan: A preclinical study.

endoscopic mucosal resection endoscopic resection endoscopic submucosal dissection phosphorylated pullulan submucosal injection

Journal

Gastrointestinal endoscopy
ISSN: 1097-6779
Titre abrégé: Gastrointest Endosc
Pays: United States
ID NLM: 0010505

Informations de publication

Date de publication:
13 Jan 2024
Historique:
received: 21 11 2023
revised: 25 12 2023
accepted: 10 01 2024
medline: 16 1 2024
pubmed: 16 1 2024
entrez: 15 1 2024
Statut: aheadofprint

Résumé

The submucosal injection solution is used to assist in endoscopic surgery. The high viscosity of current solutions makes it difficult to inject. In the present study, we developed an extremely low-viscosity, easy-to-use submucosal injection solution using phosphorylated pullulan (PPL). The PPL solutions were prepared at different concentrations, and their viscosity was measured. The mucosal elevation capacity was evaluated using excised porcine stomachs. Controls included 0.4% sodium hyaluronate (SH), 0.6% sodium alginate (SA), and saline. To evaluate the practicality, the catheter injectability of 0.7% PPL was measured, and endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) were performed using the stomach and colorectum of live pigs. As controls, 0.4% SH and saline were used. The PPL solutions were of extremely low viscosity compared to those of 0.4% SH and 0.6% SA. Nevertheless, the mucosal elevation capacity of PPL solutions for up to 0.7% concentration was similar to that of 0.4% SH, and 0.7% PPL was less resistant to catheter infusion than 0.4% SH and 0.6% SA. In live pig experiments with EMR and ESD, snaring after submucosal injection of 0.7 % PPL was easier than with 0.4% SH, and ESD with 0.7% PPL produced less bubble formation than with 0.4% SH, and the procedure time tended to be shorter with 0.7% PPL than with 0.4% SH because of the shorter injection time. The PPL solution is an innovative and easy-to-use submucosal injection solution.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
The submucosal injection solution is used to assist in endoscopic surgery. The high viscosity of current solutions makes it difficult to inject. In the present study, we developed an extremely low-viscosity, easy-to-use submucosal injection solution using phosphorylated pullulan (PPL).
METHODS METHODS
The PPL solutions were prepared at different concentrations, and their viscosity was measured. The mucosal elevation capacity was evaluated using excised porcine stomachs. Controls included 0.4% sodium hyaluronate (SH), 0.6% sodium alginate (SA), and saline. To evaluate the practicality, the catheter injectability of 0.7% PPL was measured, and endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) were performed using the stomach and colorectum of live pigs. As controls, 0.4% SH and saline were used.
RESULTS RESULTS
The PPL solutions were of extremely low viscosity compared to those of 0.4% SH and 0.6% SA. Nevertheless, the mucosal elevation capacity of PPL solutions for up to 0.7% concentration was similar to that of 0.4% SH, and 0.7% PPL was less resistant to catheter infusion than 0.4% SH and 0.6% SA. In live pig experiments with EMR and ESD, snaring after submucosal injection of 0.7 % PPL was easier than with 0.4% SH, and ESD with 0.7% PPL produced less bubble formation than with 0.4% SH, and the procedure time tended to be shorter with 0.7% PPL than with 0.4% SH because of the shorter injection time.
CONCLUSIONS CONCLUSIONS
The PPL solution is an innovative and easy-to-use submucosal injection solution.

Identifiants

pubmed: 38224821
pii: S0016-5107(24)00020-8
doi: 10.1016/j.gie.2024.01.015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Auteurs

Takuya Satomi (T)

Department of Gastroenterology and Hepatology.

Yukari Ochi (Y)

Department of Pathology and Experimental Medicine, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan.

Takumi Okihara (T)

Faculty of Environmental, Life, Natural Science and Technology, Okayama University, Okayama, Japan.

Hiroki Fujii (H)

Department of Pathology and Experimental Medicine, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan.

Yasuhiro Yoshida (Y)

Faculty of Dental Medicine, Department of Biomaterials and Bioengineering, Hokkaido University, Sapporo, Japan.

Katsumi Mominoki (K)

Department of Animal Resources, Advanced Science Research Center, Okayama University, Okayama, Japan.

Haruko Hirayama (H)

Department of Animal Resources, Advanced Science Research Center, Okayama University, Okayama, Japan.

Junki Toyosawa (J)

Department of Gastroenterology and Hepatology.

Yasushi Yamasaki (Y)

Department of Gastroenterology and Hepatology.

Seiji Kawano (S)

Department of Gastroenterology and Hepatology.

Yoshiro Kawahara (Y)

Department of Practical Gastrointestinal Endoscopy, Okayama University, Okayama, Japan.

Hiroyuki Okada (H)

Department of Gastroenterology and Hepatology,; Department of Internal Medicine, Japanese Red Cross Society Himeji Hospital, Himeji, Japan.

Motoyuki Otsuka (M)

Department of Gastroenterology and Hepatology.

Akihiro Matsukawa (A)

Department of Pathology and Experimental Medicine, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan.

Classifications MeSH